- CAR T-cell therapy
David L. Porter, MD
Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Penn Medicine Provider
About me
- Director, Cell Therapy and Transplant
- Jodi Fisher Horowitz Professor in Leukemia Care Excellence
My education and training
- Medical School: Brown University
- Residency: Boston Medical Center
- Fellowship: Mass General Brigham Healthcare Center - Chestnut Hill
Spoken languages
English
English
Reviews
328 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Hematology, 1994
- American Society for Transplantation and Cellular Therapy, National
- American Society for Transplantation and Cellular Therapy, National
- American Society of Clinical Oncology (Member), National
- American Society of Hematology, National
- American Society of Hematology (Member), National
- Association of American Cancer Institutes, National
- Cancer Support Community of Greater Philadelphia, Local
- Center for International Blood and Marrow Transplant Registry, Chronic Leukemia Working Committee., International
- Center for International Blood and Marrow Transplant Registry, Graft-vs-Host Disease/Immune Reconstitution Working Committee, International
- Cure Sickle Cell Initiative (CureSCi) External Scientific Panel, National Heart Lung and Blood Institute, National
- Foundation for the Accreditation of Cellular Therapy CAR-T Cell Task Force, National
- Medical Resource Council, Gilda’s Club, Bucks/Mont Countie, Local
- National Marrow Donor Program, National
- NMDP, National
- Society for the Immunotherapy of Cancer (SITC), National
- Penn Bone Marrow Transplant and Stem Cell Transplant Program
- Penn Cellular Therapy and Transplant Program
- Penn Hematological Malignancies (Blood Cancer) Program
- Penn Leukemia Program
- Penn Lymphoma Program
- Penn Telomere Biology Disorders Program
- Recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2025
Treatments and conditions
Research
Publications
Porter DL, Levine BL, Kalos M, Bagg A, June CH Delayed tumor lysis and CLL remission from chimeric antigen receptor modified T cells , New England Journal of Medicine, 365: 2011,725-733
Reshef R, Luger S, Hexner EO, Loren AW, Frey NV, Nasta SD, Goldstein SC, Stadmauer EA, Smith J, Bailey S, Mick R, Heitjan DF, Emerson SG, Hoxie JA, Vonderheide RH, Porter DL. Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease , New England Journal of Medicine, 367: 2012,135-145
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells expressing chimeric receptors establish memory and potent antitumor effects in patients with advanced leukemia , Science Translational Medicine, 3: 2011,95ra73
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL. Peripheral blood stem cells versus bone marrow from unrelated donors: results of Blood and Marrow Transplant Clinical Trials Network protocol 0201, a phase III, prospective, randomized trial. , New England Journal of Medicine, 367: 2012,1487-1496
Porter DL, Alyea EP, Antin JH, DeLima M, Estey, E, Falkenburg JHF, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. , Biol Blood and Marrow Transplant, 16: 2010,1467-1503
Tizon R, Frey N, Heitjan DF, Tan KS, Goldstein SC, Hexner EO, Loren A, Luger SM, Reshef R, Tsai D, Vogl D, Davis J, Vozniak M, Fuchs B, Stadtmauer EA, Porter DL. High dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allogeneic SCT. , Bone Marrow Transplant, 47: 2011,1332-1337
Rager A, Frey N, Goldstein SC, Reshef R, Hexner EO, Loren A, Luger SM, Perl, A, Tsai D, Davis J, Vozniak M, Smith J, Stadtmauer EA, Porter DL. Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease , Bone Marrow Transplantation, epub: 2010
Paralkar VR, Nasta SD, Morrissey K, Smith J, Vassilev P, Martin ME, Goldstein SC, Loren A, Rook AH, Kim EJ, Porter DL. Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas , Bone Marrow Transplantation, 47: 2012,940-945
Rager A, Porter DL Cellular therapy following allogeneic stem cell transplantation , Therapeutic Advances in Hematology, 2(6): 2011,416 - 435.
Goldstein SC, Porter DL Allogeneic immunotherapy to optimize the graft-versus tumor effect: concepts and controversies. , Expert Review of Hematology, 3(3): 2010,301-314